chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site macule
Clinical narrative: 9 cm x 15 cm area of non-tender, macular erythema distal to the injection site on the left arm.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Patient got DVT within one week after receiving the Covid Booster vaccine, which FNP-C felt was highly suspicious.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I began symptoms on 09/07/2022 with a sore throat. I contacted my healthcare provider over their messaging system. Later that day, I did a home test and tested positive. My doctor returned my phone call the next morning 09/08/2022 and they told me that I did not necessarily qualify for any medication because I didn't have any long standing health conditions, but because of my age, they prescribed PAXLOVID. I picked up the prescription on 09/08/2022 and began taking the dosage for 5 days. On 09/09, I had a runny nose. 09/10 and 09/11 I had a dry cough. On 09/12, I felt great with no symptoms at all. I took my last dose of PAXLOVID on 09/13 in the morning. 09/18, I developed symptoms again such as sneezing, coughing and a sore throat. I tested positive again. I took over the counter medication on 09/18 and 09/19. On the 19th, I started to feel somewhat better. On 09/25/2022, I did another home test and tested negative. I had a dry cough for another 10 days after that.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: I began symptoms on 09/07/2022 with a sore throat. I contacted my healthcare provider over their messaging system. Later that day, I did a home test and tested positive. My doctor returned my phone call the next morning 09/08/2022 and they told me that I did not necessarily qualify for any medication because I didn't have any long standing health conditions, but because of my age, they prescribed PAXLOVID. I picked up the prescription on 09/08/2022 and began taking the dosage for 5 days. On 09/09, I had a runny nose. 09/10 and 09/11 I had a dry cough. On 09/12, I felt great with no symptoms at all. I took my last dose of PAXLOVID on 09/13 in the morning. 09/18, I developed symptoms again such as sneezing, coughing and a sore throat. I tested positive again. I took over the counter medication on 09/18 and 09/19. On the 19th, I started to feel somewhat better. On 09/25/2022, I did another home test and tested negative. I had a dry cough for another 10 days after that.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.   Patient/caregiver did not report any adverse event.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Pain, Paraesthesia
Clinical narrative: states developed sx of sore throat, dry cough, body aches, and "tingly body" on 11/20/22 reports that she tested positive for covid on home test 11/22/22
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: states developed sx of sore throat, dry cough, body aches, and "tingly body" on 11/20/22 reports that she tested positive for covid on home test 11/22/22
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.   Patient/caregiver did not report any adverse event.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chemotherapy, Chest X-ray abnormal, Chills
Clinical narrative: Patient is a 75 y.o. female patient of PRIVATE, MD presented headache, nausea and chills and was found to be COVID-positive.   She has a background history of breast ca and hyperlipidemia.   Nausea/Chills/Headache Diarrhea She is afebrile at present, still with nausea. Symptoms likely due to COVID. She was on chemotherapy. Antiemetics and fluid hydration. No further nausea vomiting or diarrhea.   Covid-19 Virus Infection Date of onset of symptoms: 11/1/22 Symptoms present on admission: nausea, headache Date of covid positive test: 11/2/22 Vaccination status: vaccinated Imaging: CXR-atelectasis vs. Early infiltrate Oxygen requirements on admission: none Current oxygen requirements:none Medical therapy: Remdesivir Consultants following: ID  Anticipated special isolation end date: 11/12/22    Remains on room air.  No cough.  Afebrile.  No need for further medications.   Hypokalemia Corrected. Monitor other electrolytes and correct deficits.   Breast cancer Neutropenia History of hormone receptor positive metastatic breast carcinoma, on therapy with palbociclib and letrozole. Neutropenia likely chemotherapy-induced. Appreciate oncology input. Hold off on growth factor for now. Hold palbociclib at discharge, continue Letrozole.  Repeat CBC next week before starting palbociclib.  Dr. to follow.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Hypokalaemia, Lung infiltration, Nausea
Clinical narrative: Patient is a 75 y.o. female patient of PRIVATE, MD presented headache, nausea and chills and was found to be COVID-positive.   She has a background history of breast ca and hyperlipidemia.   Nausea/Chills/Headache Diarrhea She is afebrile at present, still with nausea. Symptoms likely due to COVID. She was on chemotherapy. Antiemetics and fluid hydration. No further nausea vomiting or diarrhea.   Covid-19 Virus Infection Date of onset of symptoms: 11/1/22 Symptoms present on admission: nausea, headache Date of covid positive test: 11/2/22 Vaccination status: vaccinated Imaging: CXR-atelectasis vs. Early infiltrate Oxygen requirements on admission: none Current oxygen requirements:none Medical therapy: Remdesivir Consultants following: ID  Anticipated special isolation end date: 11/12/22    Remains on room air.  No cough.  Afebrile.  No need for further medications.   Hypokalemia Corrected. Monitor other electrolytes and correct deficits.   Breast cancer Neutropenia History of hormone receptor positive metastatic breast carcinoma, on therapy with palbociclib and letrozole. Neutropenia likely chemotherapy-induced. Appreciate oncology input. Hold off on growth factor for now. Hold palbociclib at discharge, continue Letrozole.  Repeat CBC next week before starting palbociclib.  Dr. to follow.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Neutropenia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 75 y.o. female patient of PRIVATE, MD presented headache, nausea and chills and was found to be COVID-positive.   She has a background history of breast ca and hyperlipidemia.   Nausea/Chills/Headache Diarrhea She is afebrile at present, still with nausea. Symptoms likely due to COVID. She was on chemotherapy. Antiemetics and fluid hydration. No further nausea vomiting or diarrhea.   Covid-19 Virus Infection Date of onset of symptoms: 11/1/22 Symptoms present on admission: nausea, headache Date of covid positive test: 11/2/22 Vaccination status: vaccinated Imaging: CXR-atelectasis vs. Early infiltrate Oxygen requirements on admission: none Current oxygen requirements:none Medical therapy: Remdesivir Consultants following: ID  Anticipated special isolation end date: 11/12/22    Remains on room air.  No cough.  Afebrile.  No need for further medications.   Hypokalemia Corrected. Monitor other electrolytes and correct deficits.   Breast cancer Neutropenia History of hormone receptor positive metastatic breast carcinoma, on therapy with palbociclib and letrozole. Neutropenia likely chemotherapy-induced. Appreciate oncology input. Hold off on growth factor for now. Hold palbociclib at discharge, continue Letrozole.  Repeat CBC next week before starting palbociclib.  Dr. to follow.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 09/13/2022. I started to experience congestion sore throat sneezing on 11/04/2022. I tested COVID-19 positive on 11/04/2022. I was prescribed PAXLOVID but did not take. I am feeling almost back to normal on 11/22/2022 with some residual congestion and fatigue.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Sneezing
Clinical narrative: I had my vaccination on 09/13/2022. I started to experience congestion sore throat sneezing on 11/04/2022. I tested COVID-19 positive on 11/04/2022. I was prescribed PAXLOVID but did not take. I am feeling almost back to normal on 11/22/2022 with some residual congestion and fatigue.
Age: 8.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 1.25
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Extra dose administered
Clinical narrative: Appointment was scheduled as a COVID Dose #2. The vaccinator did not perform a thorough chart investigation prior to administering what she believed was dose #2 of Moderna 6m-5y. When she attempted to document, she received a warning that the dose was not due and should not be administered as the patient had completed the series. Patient had already received the dose.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19-2, FLUA4
Symptoms: Bell's palsy, Blood glucose normal, Eye disorder, Facial paralysis, Mobility decreased
Clinical narrative: On 11/2/2022 my inner mouth started to feel slightly puffy. I looked at my face & realized I had right facial droop, was unable to close right eye, & eyebrows were uneven. I am a nurse & had spouse assist with neuro checks & all were WNL, HG strong equal, pupils equal & reactive to light, able to raise arms/legs equally & hold up w/out difficulty. Decided to call PCP in a.m. as there were no neuro deficits noted.  When called PCP office in a.m. was instructed to go to ER to rule out a stroke.  Examined by ER physician (DO) & was diagnosed with Bell's Palsy.  He prescribed: Prednisone 20mg- 3 tablets po once daily (quantitiy 21)  &  Acyclovir 400mg- 1 tablet po 5 times daily (quantity 50).  Intructed to use eyedrops/oint. frequently to keep eye moist & wear eye patch or tape eye closed at night to prevent corneal damage.  Make appt with PCP in 2-3 days for follow-up.  Return to ER if symptoms worsen.  Today is 11/22/2022 & my symptoms are pretty well resolved.  All ER meds. that were prescribed have been completed as ordered.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19-2, FLUA4
Symptoms: Mouth swelling
Clinical narrative: On 11/2/2022 my inner mouth started to feel slightly puffy. I looked at my face & realized I had right facial droop, was unable to close right eye, & eyebrows were uneven. I am a nurse & had spouse assist with neuro checks & all were WNL, HG strong equal, pupils equal & reactive to light, able to raise arms/legs equally & hold up w/out difficulty. Decided to call PCP in a.m. as there were no neuro deficits noted.  When called PCP office in a.m. was instructed to go to ER to rule out a stroke.  Examined by ER physician (DO) & was diagnosed with Bell's Palsy.  He prescribed: Prednisone 20mg- 3 tablets po once daily (quantitiy 21)  &  Acyclovir 400mg- 1 tablet po 5 times daily (quantity 50).  Intructed to use eyedrops/oint. frequently to keep eye moist & wear eye patch or tape eye closed at night to prevent corneal damage.  Make appt with PCP in 2-3 days for follow-up.  Return to ER if symptoms worsen.  Today is 11/22/2022 & my symptoms are pretty well resolved.  All ER meds. that were prescribed have been completed as ordered.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 17.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Loss of consciousness, Syncope
Clinical narrative: Syncopal episode with LOC of approximately 10 seconds
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Malaise, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: On 10/02/2022 at 11:00AM, I was sent home from work because I wasn't feeling well. I had extremely high fever. I went to my doctor's office at around 3:00PM on the same day. I had a fever of 100.00. My doctor prescribed me with antibiotics for 4-5 days. He wasn't sure what was happening with me. He advised me to contact him if my fever gets worse. I also took BENADRYL for 2 nights seems like its working.
Age: 8.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 30.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, Influenza virus test negative, Nausea, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: fever up to 104, joint aches, nausea, vomiting
Age: 30.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Vomiting
Clinical narrative: fever up to 104, joint aches, nausea, vomiting
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered, Product administered to patient of inappropriate age
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Peripheral swelling
Clinical narrative: developed a raised palpable bump on arm (no hives, itchiness swelling, SOB, difficulty breathing) iced area in clinic and gave ice pack to take home with her, gave 10mg zyrtec by mouth and 20mg pepcid by mouth at clinic. patient left on her own, feeling fine
Age: 11.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Cardiac failure, Chest discomfort, Chest pain
Clinical narrative: Patient is a 61 y.o. female patient of MD with a history of chest pain and dizziness.  Patient states that she has been diagnosed with blood clots in her legs recently and was started on Eliquis yesterday.  States that she has been having inferior substernal chest pains a mix of sharpness and pressure, over the last 3 days.  Does note that she feels short of breath.  States that she has been having fevers and chills.  Does note that she has been dizzy.  States that her husband is here in the hospital for chest pain and she has been with him upstairs.  States that the symptoms were such that she felt that she needed to be evaluated as she became deeply concerned.  Has had a dry cough.  States that she thought that she was "just getting a cold".  Has also felt nauseated over the last 4 days, worse over the last 3 days.  Denies additional clinical concerns at this time. No hypoxia, pt stabilized dced home , eliquis resumed from outpt dvt   Discharge Diagnoses:   Covid Dm Htn Dvt HFpEF SVT
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Diabetes mellitus, Dizziness, Dyspnoea
Clinical narrative: Patient is a 61 y.o. female patient of MD with a history of chest pain and dizziness.  Patient states that she has been diagnosed with blood clots in her legs recently and was started on Eliquis yesterday.  States that she has been having inferior substernal chest pains a mix of sharpness and pressure, over the last 3 days.  Does note that she feels short of breath.  States that she has been having fevers and chills.  Does note that she has been dizzy.  States that her husband is here in the hospital for chest pain and she has been with him upstairs.  States that the symptoms were such that she felt that she needed to be evaluated as she became deeply concerned.  Has had a dry cough.  States that she thought that she was "just getting a cold".  Has also felt nauseated over the last 4 days, worse over the last 3 days.  Denies additional clinical concerns at this time. No hypoxia, pt stabilized dced home , eliquis resumed from outpt dvt   Discharge Diagnoses:   Covid Dm Htn Dvt HFpEF SVT
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Nausea, Pyrexia, Supraventricular tachycardia, Thrombosis
Clinical narrative: Patient is a 61 y.o. female patient of MD with a history of chest pain and dizziness.  Patient states that she has been diagnosed with blood clots in her legs recently and was started on Eliquis yesterday.  States that she has been having inferior substernal chest pains a mix of sharpness and pressure, over the last 3 days.  Does note that she feels short of breath.  States that she has been having fevers and chills.  Does note that she has been dizzy.  States that her husband is here in the hospital for chest pain and she has been with him upstairs.  States that the symptoms were such that she felt that she needed to be evaluated as she became deeply concerned.  Has had a dry cough.  States that she thought that she was "just getting a cold".  Has also felt nauseated over the last 4 days, worse over the last 3 days.  Denies additional clinical concerns at this time. No hypoxia, pt stabilized dced home , eliquis resumed from outpt dvt   Discharge Diagnoses:   Covid Dm Htn Dvt HFpEF SVT
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered, Product administered to patient of inappropriate age
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 9.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered, Product administered to patient of inappropriate age
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, Blood magnesium normal, Blood sodium increased
Clinical narrative: Clinical Summary Patient is a 98 y.o. female with a history of COPD and RA presented to hospital11/6/2022 with SOB, Cough, and sputum production. Found to have COVID-19 infection. Improved with steroids. Discharged to SNF 11/9/22.    1. COVID-19 Infection: Vaccinated with Pfizer 1/2021 and 2/2021 without booster. Sx starting 10/28/2022. Mild URI symptoms at that point. On 2L NC on admission. Isolation initiated. Out of window for other therapies. Antitussives prn. Given decadron for 10 day course end date 11/15/22.  2. Acute Hypoxic respiratory failure: Not on O2 at baseline, required 2L NC in ED. Treatment as above. Improved. 3. COPD: Not on O2 at home. Mild cough and URI symptoms since 10/28. Continued home inhaler regimen. 4. AKI: Secondary to poor PO intake in the setting of an infection. Improved with gentle IVF. Baseline Cr 0.9. Cr 1.61 on admission. UA positive without symptoms and Renal US without hydronephrosis. + 10mm renal calculus non obstructive. Cr 0.57 11/9/22. 5. Positive D-Dimer: pt denied h/o thrombosis. No calf pain. Pt elected to defer further imaging/testing to r/o PE.  6. Asymptomatic Pyuria: without symptoms. Urine Cx contaminated. No indication for antibiotic therapy. 7. HTN: started norvasc. Stopped chlorthalidone and losartan 8. Hypernatremia: Na up to 149 and started D5W IVF 11/8/22. Suspect related to poor po intake. Improved. 9. Hypokalemia: Secondary to poor PO intake. Replaced. Mag wnl. Improved. 10. Hyperglycemia: Secondary to stress. No history of DM. Monitored with steroids.  11. Iron Deficiency Anemia: Per history. Baseline Hgb 10. Hgb 10 on admission. Continued home iron replacement.  12. Rheumatoid arthritis: continued home meds 13. Code status: DNR CCA DNI
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Culture urine, Dyspnoea, Fibrin D dimer increased
Clinical narrative: Clinical Summary Patient is a 98 y.o. female with a history of COPD and RA presented to hospital11/6/2022 with SOB, Cough, and sputum production. Found to have COVID-19 infection. Improved with steroids. Discharged to SNF 11/9/22.    1. COVID-19 Infection: Vaccinated with Pfizer 1/2021 and 2/2021 without booster. Sx starting 10/28/2022. Mild URI symptoms at that point. On 2L NC on admission. Isolation initiated. Out of window for other therapies. Antitussives prn. Given decadron for 10 day course end date 11/15/22.  2. Acute Hypoxic respiratory failure: Not on O2 at baseline, required 2L NC in ED. Treatment as above. Improved. 3. COPD: Not on O2 at home. Mild cough and URI symptoms since 10/28. Continued home inhaler regimen. 4. AKI: Secondary to poor PO intake in the setting of an infection. Improved with gentle IVF. Baseline Cr 0.9. Cr 1.61 on admission. UA positive without symptoms and Renal US without hydronephrosis. + 10mm renal calculus non obstructive. Cr 0.57 11/9/22. 5. Positive D-Dimer: pt denied h/o thrombosis. No calf pain. Pt elected to defer further imaging/testing to r/o PE.  6. Asymptomatic Pyuria: without symptoms. Urine Cx contaminated. No indication for antibiotic therapy. 7. HTN: started norvasc. Stopped chlorthalidone and losartan 8. Hypernatremia: Na up to 149 and started D5W IVF 11/8/22. Suspect related to poor po intake. Improved. 9. Hypokalemia: Secondary to poor PO intake. Replaced. Mag wnl. Improved. 10. Hyperglycemia: Secondary to stress. No history of DM. Monitored with steroids.  11. Iron Deficiency Anemia: Per history. Baseline Hgb 10. Hgb 10 on admission. Continued home iron replacement.  12. Rheumatoid arthritis: continued home meds 13. Code status: DNR CCA DNI
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hyperglycaemia, Hypernatraemia, Hypertension, Hypokalaemia
Clinical narrative: Clinical Summary Patient is a 98 y.o. female with a history of COPD and RA presented to hospital11/6/2022 with SOB, Cough, and sputum production. Found to have COVID-19 infection. Improved with steroids. Discharged to SNF 11/9/22.    1. COVID-19 Infection: Vaccinated with Pfizer 1/2021 and 2/2021 without booster. Sx starting 10/28/2022. Mild URI symptoms at that point. On 2L NC on admission. Isolation initiated. Out of window for other therapies. Antitussives prn. Given decadron for 10 day course end date 11/15/22.  2. Acute Hypoxic respiratory failure: Not on O2 at baseline, required 2L NC in ED. Treatment as above. Improved. 3. COPD: Not on O2 at home. Mild cough and URI symptoms since 10/28. Continued home inhaler regimen. 4. AKI: Secondary to poor PO intake in the setting of an infection. Improved with gentle IVF. Baseline Cr 0.9. Cr 1.61 on admission. UA positive without symptoms and Renal US without hydronephrosis. + 10mm renal calculus non obstructive. Cr 0.57 11/9/22. 5. Positive D-Dimer: pt denied h/o thrombosis. No calf pain. Pt elected to defer further imaging/testing to r/o PE.  6. Asymptomatic Pyuria: without symptoms. Urine Cx contaminated. No indication for antibiotic therapy. 7. HTN: started norvasc. Stopped chlorthalidone and losartan 8. Hypernatremia: Na up to 149 and started D5W IVF 11/8/22. Suspect related to poor po intake. Improved. 9. Hypokalemia: Secondary to poor PO intake. Replaced. Mag wnl. Improved. 10. Hyperglycemia: Secondary to stress. No history of DM. Monitored with steroids.  11. Iron Deficiency Anemia: Per history. Baseline Hgb 10. Hgb 10 on admission. Continued home iron replacement.  12. Rheumatoid arthritis: continued home meds 13. Code status: DNR CCA DNI
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Infection, Nephrolithiasis, Productive cough, Pyuria
Clinical narrative: Clinical Summary Patient is a 98 y.o. female with a history of COPD and RA presented to hospital11/6/2022 with SOB, Cough, and sputum production. Found to have COVID-19 infection. Improved with steroids. Discharged to SNF 11/9/22.    1. COVID-19 Infection: Vaccinated with Pfizer 1/2021 and 2/2021 without booster. Sx starting 10/28/2022. Mild URI symptoms at that point. On 2L NC on admission. Isolation initiated. Out of window for other therapies. Antitussives prn. Given decadron for 10 day course end date 11/15/22.  2. Acute Hypoxic respiratory failure: Not on O2 at baseline, required 2L NC in ED. Treatment as above. Improved. 3. COPD: Not on O2 at home. Mild cough and URI symptoms since 10/28. Continued home inhaler regimen. 4. AKI: Secondary to poor PO intake in the setting of an infection. Improved with gentle IVF. Baseline Cr 0.9. Cr 1.61 on admission. UA positive without symptoms and Renal US without hydronephrosis. + 10mm renal calculus non obstructive. Cr 0.57 11/9/22. 5. Positive D-Dimer: pt denied h/o thrombosis. No calf pain. Pt elected to defer further imaging/testing to r/o PE.  6. Asymptomatic Pyuria: without symptoms. Urine Cx contaminated. No indication for antibiotic therapy. 7. HTN: started norvasc. Stopped chlorthalidone and losartan 8. Hypernatremia: Na up to 149 and started D5W IVF 11/8/22. Suspect related to poor po intake. Improved. 9. Hypokalemia: Secondary to poor PO intake. Replaced. Mag wnl. Improved. 10. Hyperglycemia: Secondary to stress. No history of DM. Monitored with steroids.  11. Iron Deficiency Anemia: Per history. Baseline Hgb 10. Hgb 10 on admission. Continued home iron replacement.  12. Rheumatoid arthritis: continued home meds 13. Code status: DNR CCA DNI
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory symptom, Stress, Ultrasound kidney abnormal, Urine analysis abnormal
Clinical narrative: Clinical Summary Patient is a 98 y.o. female with a history of COPD and RA presented to hospital11/6/2022 with SOB, Cough, and sputum production. Found to have COVID-19 infection. Improved with steroids. Discharged to SNF 11/9/22.    1. COVID-19 Infection: Vaccinated with Pfizer 1/2021 and 2/2021 without booster. Sx starting 10/28/2022. Mild URI symptoms at that point. On 2L NC on admission. Isolation initiated. Out of window for other therapies. Antitussives prn. Given decadron for 10 day course end date 11/15/22.  2. Acute Hypoxic respiratory failure: Not on O2 at baseline, required 2L NC in ED. Treatment as above. Improved. 3. COPD: Not on O2 at home. Mild cough and URI symptoms since 10/28. Continued home inhaler regimen. 4. AKI: Secondary to poor PO intake in the setting of an infection. Improved with gentle IVF. Baseline Cr 0.9. Cr 1.61 on admission. UA positive without symptoms and Renal US without hydronephrosis. + 10mm renal calculus non obstructive. Cr 0.57 11/9/22. 5. Positive D-Dimer: pt denied h/o thrombosis. No calf pain. Pt elected to defer further imaging/testing to r/o PE.  6. Asymptomatic Pyuria: without symptoms. Urine Cx contaminated. No indication for antibiotic therapy. 7. HTN: started norvasc. Stopped chlorthalidone and losartan 8. Hypernatremia: Na up to 149 and started D5W IVF 11/8/22. Suspect related to poor po intake. Improved. 9. Hypokalemia: Secondary to poor PO intake. Replaced. Mag wnl. Improved. 10. Hyperglycemia: Secondary to stress. No history of DM. Monitored with steroids.  11. Iron Deficiency Anemia: Per history. Baseline Hgb 10. Hgb 10 on admission. Continued home iron replacement.  12. Rheumatoid arthritis: continued home meds 13. Code status: DNR CCA DNI
Age: 7.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Potential use of expired Pfizer Pediatric Vaccine. Received information from the manufacturer indicating that stability data supports the use of this product for 18 months.
Age: 67.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Incorrect dose administered
Clinical narrative: INADVERTANTLY GAVE REGULAR DOSE INSTEAD OF HIGH DOSE- (WAS AVAILABLE) CLIENT NOTIFIED BY NURSE
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial pain, Hypoaesthesia, Magnetic resonance imaging head normal, Paraesthesia, Scan with contrast normal
Clinical narrative: One week after receiving my second shingrix vaccine I experienced left sided facial numbness with tingling a slight pain. I went to my dentist and was examined, had a x-ray that was normal. The interior left side of my cheek was swollen to the size of half a golf ball, I was referred to an oral surgeon who has referred me to a neurologist. I had a brain mri with contrast focusing on my cranial nerves, everything  was fine. I am a retired nurse and feel as this may be related to my vaccine. A nurse practioner that worked with me just informed me that right after her shingrex vaccine she is have numbness and slight pain on part of her lower left arm. I just wondering if these symptoms are related to the vaccine...I am baffled.  Thank you.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling face, X-ray dental normal
Clinical narrative: One week after receiving my second shingrix vaccine I experienced left sided facial numbness with tingling a slight pain. I went to my dentist and was examined, had a x-ray that was normal. The interior left side of my cheek was swollen to the size of half a golf ball, I was referred to an oral surgeon who has referred me to a neurologist. I had a brain mri with contrast focusing on my cranial nerves, everything  was fine. I am a retired nurse and feel as this may be related to my vaccine. A nurse practioner that worked with me just informed me that right after her shingrex vaccine she is have numbness and slight pain on part of her lower left arm. I just wondering if these symptoms are related to the vaccine...I am baffled.  Thank you.
Age: 34.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Laboratory test abnormal, Seizure
Clinical narrative: Brief seizure occurred shortly after vaccines were administered as patient was leaving the office.  He recovered quickly and had no lingering effects.  His Depakote level was checked later in the day and found to be low.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eye swelling, Vision blurred
Clinical narrative: PER PATIENT RIGHT EYE SWELLED UP CAUSING BLURRY VISION. PATIENT SAW ophthalmologist. OPTHALMOLOGIST NOTED THE WORSENING IN VISION OF RIGHT EYE ONLY  AS COMPARED TO THE RESULTS OF A VISIT 2 MONTHS PRIOR. PER PATIENT SWELLING RESOLVED ON IT'S OWN IN ABOUT A WEEK
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills
Clinical narrative: chills,
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Dr. ordered a third Moderna Monovalent 6m-5y for a non-immunocompromised 2 year old patient.  I prepared and administered this dose initially thinking  I was giving a second dose, and afterwards realizing it was the third.  Reviewed this later in the day with Dr.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Grip strength decreased, Injected limb mobility decreased, Injection site pain
Clinical narrative: Pain in right shoulder.  Limited range of motion.  Unable to reach or hold much much weight with it.  Has gotten worse and worse over time.  At first I thought it was just initial pain from the shot that would go away but it has not gone away and has gotten to the point now where I can hardly move it without any pain and it hurts even without moving it.
Age: 89.0
Sex: F
Vaccine: FLU4
Symptoms: Underdose
Clinical narrative: Gave a standard dose to a patient that needed High dose.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain, Acute kidney injury, Acute respiratory failure, Alanine aminotransferase increased, Aspartate aminotransferase increased
Clinical narrative: Clinical Summary The patient is a 77 year old  female with a history of Cognitive Impairment due to PML, MGUS, and PE who presented on 10/31/22 with fevers/abdominal pain x 7 days PTA, Abdominal pain. Found to have COVID, choledocholithiasis, possible UTI, Cr 1.5, AST 501, ALT 292, T bili 0.5, WBC 2.2, and Hgb  9. Transferred to hospital 11/1/2022 for further management.  Discharged home.   1. Sepsis with Leukopenia: secondary to COVID. Blood/urine cultures negative.  Resolved. 2. COVID PNA: Vaccinated x 4 (last 10/1/22, likely non-responder given MGUS) symptom onset 10/24/22, (+)test 10/31/22. Admit CXR with atelectasis in LLL.  Given Decadron while inpatient, discontinued at discharge.  Isolation no longer required. 3. Acute Hypoxic Respiratory Failure: secondary to  COVID-19 infection. Required 2L NC on admit.  4. Elevated Liver Enzymes: Per GI, likely multifactorial from COVID, DILI from Keflex/Tylenol, and underlying fatty liver disease.  Patient took 3 Tylenol tabs every 4 hours x3 days PTA.  Admit AST 501, ALT 292.  Hepatitis panel unremarkable.  Showed CT Abdomen/Pelvis  10/31/22: GB sludge with cholelithiasis.  RUQ US showed cholelithiasis.  Held lipitor.  General Surgery followed.  GI followed, recommended CMP weekly x 4 weeks. 5. AKI: Baseline Cr 0.8, Cr 1.5 on admit due to sepsis.  Resolved.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atelectasis, Bile duct stone, Blood bilirubin normal, Blood creatinine increased, Blood culture negative
Clinical narrative: Clinical Summary The patient is a 77 year old  female with a history of Cognitive Impairment due to PML, MGUS, and PE who presented on 10/31/22 with fevers/abdominal pain x 7 days PTA, Abdominal pain. Found to have COVID, choledocholithiasis, possible UTI, Cr 1.5, AST 501, ALT 292, T bili 0.5, WBC 2.2, and Hgb  9. Transferred to hospital 11/1/2022 for further management.  Discharged home.   1. Sepsis with Leukopenia: secondary to COVID. Blood/urine cultures negative.  Resolved. 2. COVID PNA: Vaccinated x 4 (last 10/1/22, likely non-responder given MGUS) symptom onset 10/24/22, (+)test 10/31/22. Admit CXR with atelectasis in LLL.  Given Decadron while inpatient, discontinued at discharge.  Isolation no longer required. 3. Acute Hypoxic Respiratory Failure: secondary to  COVID-19 infection. Required 2L NC on admit.  4. Elevated Liver Enzymes: Per GI, likely multifactorial from COVID, DILI from Keflex/Tylenol, and underlying fatty liver disease.  Patient took 3 Tylenol tabs every 4 hours x3 days PTA.  Admit AST 501, ALT 292.  Hepatitis panel unremarkable.  Showed CT Abdomen/Pelvis  10/31/22: GB sludge with cholelithiasis.  RUQ US showed cholelithiasis.  Held lipitor.  General Surgery followed.  GI followed, recommended CMP weekly x 4 weeks. 5. AKI: Baseline Cr 0.8, Cr 1.5 on admit due to sepsis.  Resolved.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cholelithiasis, Computerised tomogram abdomen abnormal
Clinical narrative: Clinical Summary The patient is a 77 year old  female with a history of Cognitive Impairment due to PML, MGUS, and PE who presented on 10/31/22 with fevers/abdominal pain x 7 days PTA, Abdominal pain. Found to have COVID, choledocholithiasis, possible UTI, Cr 1.5, AST 501, ALT 292, T bili 0.5, WBC 2.2, and Hgb  9. Transferred to hospital 11/1/2022 for further management.  Discharged home.   1. Sepsis with Leukopenia: secondary to COVID. Blood/urine cultures negative.  Resolved. 2. COVID PNA: Vaccinated x 4 (last 10/1/22, likely non-responder given MGUS) symptom onset 10/24/22, (+)test 10/31/22. Admit CXR with atelectasis in LLL.  Given Decadron while inpatient, discontinued at discharge.  Isolation no longer required. 3. Acute Hypoxic Respiratory Failure: secondary to  COVID-19 infection. Required 2L NC on admit.  4. Elevated Liver Enzymes: Per GI, likely multifactorial from COVID, DILI from Keflex/Tylenol, and underlying fatty liver disease.  Patient took 3 Tylenol tabs every 4 hours x3 days PTA.  Admit AST 501, ALT 292.  Hepatitis panel unremarkable.  Showed CT Abdomen/Pelvis  10/31/22: GB sludge with cholelithiasis.  RUQ US showed cholelithiasis.  Held lipitor.  General Surgery followed.  GI followed, recommended CMP weekly x 4 weeks. 5. AKI: Baseline Cr 0.8, Cr 1.5 on admit due to sepsis.  Resolved.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Culture urine negative, Drug-induced liver injury, Haemoglobin decreased, Hepatic enzyme increased, Hepatitis viral test negative
Clinical narrative: Clinical Summary The patient is a 77 year old  female with a history of Cognitive Impairment due to PML, MGUS, and PE who presented on 10/31/22 with fevers/abdominal pain x 7 days PTA, Abdominal pain. Found to have COVID, choledocholithiasis, possible UTI, Cr 1.5, AST 501, ALT 292, T bili 0.5, WBC 2.2, and Hgb  9. Transferred to hospital 11/1/2022 for further management.  Discharged home.   1. Sepsis with Leukopenia: secondary to COVID. Blood/urine cultures negative.  Resolved. 2. COVID PNA: Vaccinated x 4 (last 10/1/22, likely non-responder given MGUS) symptom onset 10/24/22, (+)test 10/31/22. Admit CXR with atelectasis in LLL.  Given Decadron while inpatient, discontinued at discharge.  Isolation no longer required. 3. Acute Hypoxic Respiratory Failure: secondary to  COVID-19 infection. Required 2L NC on admit.  4. Elevated Liver Enzymes: Per GI, likely multifactorial from COVID, DILI from Keflex/Tylenol, and underlying fatty liver disease.  Patient took 3 Tylenol tabs every 4 hours x3 days PTA.  Admit AST 501, ALT 292.  Hepatitis panel unremarkable.  Showed CT Abdomen/Pelvis  10/31/22: GB sludge with cholelithiasis.  RUQ US showed cholelithiasis.  Held lipitor.  General Surgery followed.  GI followed, recommended CMP weekly x 4 weeks. 5. AKI: Baseline Cr 0.8, Cr 1.5 on admit due to sepsis.  Resolved.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Leukopenia, Pyrexia, SARS-CoV-2 test positive, Sepsis, Therapy non-responder
Clinical narrative: Clinical Summary The patient is a 77 year old  female with a history of Cognitive Impairment due to PML, MGUS, and PE who presented on 10/31/22 with fevers/abdominal pain x 7 days PTA, Abdominal pain. Found to have COVID, choledocholithiasis, possible UTI, Cr 1.5, AST 501, ALT 292, T bili 0.5, WBC 2.2, and Hgb  9. Transferred to hospital 11/1/2022 for further management.  Discharged home.   1. Sepsis with Leukopenia: secondary to COVID. Blood/urine cultures negative.  Resolved. 2. COVID PNA: Vaccinated x 4 (last 10/1/22, likely non-responder given MGUS) symptom onset 10/24/22, (+)test 10/31/22. Admit CXR with atelectasis in LLL.  Given Decadron while inpatient, discontinued at discharge.  Isolation no longer required. 3. Acute Hypoxic Respiratory Failure: secondary to  COVID-19 infection. Required 2L NC on admit.  4. Elevated Liver Enzymes: Per GI, likely multifactorial from COVID, DILI from Keflex/Tylenol, and underlying fatty liver disease.  Patient took 3 Tylenol tabs every 4 hours x3 days PTA.  Admit AST 501, ALT 292.  Hepatitis panel unremarkable.  Showed CT Abdomen/Pelvis  10/31/22: GB sludge with cholelithiasis.  RUQ US showed cholelithiasis.  Held lipitor.  General Surgery followed.  GI followed, recommended CMP weekly x 4 weeks. 5. AKI: Baseline Cr 0.8, Cr 1.5 on admit due to sepsis.  Resolved.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ultrasound abdomen abnormal, White blood cell count decreased
Clinical narrative: Clinical Summary The patient is a 77 year old  female with a history of Cognitive Impairment due to PML, MGUS, and PE who presented on 10/31/22 with fevers/abdominal pain x 7 days PTA, Abdominal pain. Found to have COVID, choledocholithiasis, possible UTI, Cr 1.5, AST 501, ALT 292, T bili 0.5, WBC 2.2, and Hgb  9. Transferred to hospital 11/1/2022 for further management.  Discharged home.   1. Sepsis with Leukopenia: secondary to COVID. Blood/urine cultures negative.  Resolved. 2. COVID PNA: Vaccinated x 4 (last 10/1/22, likely non-responder given MGUS) symptom onset 10/24/22, (+)test 10/31/22. Admit CXR with atelectasis in LLL.  Given Decadron while inpatient, discontinued at discharge.  Isolation no longer required. 3. Acute Hypoxic Respiratory Failure: secondary to  COVID-19 infection. Required 2L NC on admit.  4. Elevated Liver Enzymes: Per GI, likely multifactorial from COVID, DILI from Keflex/Tylenol, and underlying fatty liver disease.  Patient took 3 Tylenol tabs every 4 hours x3 days PTA.  Admit AST 501, ALT 292.  Hepatitis panel unremarkable.  Showed CT Abdomen/Pelvis  10/31/22: GB sludge with cholelithiasis.  RUQ US showed cholelithiasis.  Held lipitor.  General Surgery followed.  GI followed, recommended CMP weekly x 4 weeks. 5. AKI: Baseline Cr 0.8, Cr 1.5 on admit due to sepsis.  Resolved.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chest discomfort, Chills, Cough
Clinical narrative: It began as excessive sneezing. I then got a scratchy sore throat. Overnight it got much more like a dry scratchy cough, and I started to develop aches and pain. I developed great pressure in my chest. It got worse with sweating, chills, and unproductive cough. I retested on Tuesday, and it was positive. I felt joint and muscle pain like I could not move as well as a headache. I contacted my doctor and the triage nurse said to use 4 ibuprofen every 4 hours and 2 extra strength TYLENOL. I also used FLONASE and cough medicine. The doctor recommended MUCINEX. The COVID team prescribed PAXLOVID. My symptoms improved after 24 hours. I have a lingering cough still and I still get tired easily but that is also improving. By Saturday November 12, 2022, I was testing negative.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Mobility decreased, Myalgia
Clinical narrative: It began as excessive sneezing. I then got a scratchy sore throat. Overnight it got much more like a dry scratchy cough, and I started to develop aches and pain. I developed great pressure in my chest. It got worse with sweating, chills, and unproductive cough. I retested on Tuesday, and it was positive. I felt joint and muscle pain like I could not move as well as a headache. I contacted my doctor and the triage nurse said to use 4 ibuprofen every 4 hours and 2 extra strength TYLENOL. I also used FLONASE and cough medicine. The doctor recommended MUCINEX. The COVID team prescribed PAXLOVID. My symptoms improved after 24 hours. I have a lingering cough still and I still get tired easily but that is also improving. By Saturday November 12, 2022, I was testing negative.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, SARS-CoV-2 test positive, Sneezing, Throat irritation
Clinical narrative: It began as excessive sneezing. I then got a scratchy sore throat. Overnight it got much more like a dry scratchy cough, and I started to develop aches and pain. I developed great pressure in my chest. It got worse with sweating, chills, and unproductive cough. I retested on Tuesday, and it was positive. I felt joint and muscle pain like I could not move as well as a headache. I contacted my doctor and the triage nurse said to use 4 ibuprofen every 4 hours and 2 extra strength TYLENOL. I also used FLONASE and cough medicine. The doctor recommended MUCINEX. The COVID team prescribed PAXLOVID. My symptoms improved after 24 hours. I have a lingering cough still and I still get tired easily but that is also improving. By Saturday November 12, 2022, I was testing negative.
Age: 29.0
Sex: F
Vaccine: FLU4, HEP, MMR
Symptoms: Extra dose administered
Clinical narrative: Patient was given influenza vaccine on 11/22/22. After administration, it was discovered that patient had already received the influenza vaccine on 10/4/22.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Client received pediatric monovalent dose instead of adult bivalent dose.
Age: 44.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient recieved the Pfizer Lot FP7137 ( which is a monovalent COVID-19 vaccine) for his booster instead of the Bivalent booster. He was made aware of this and can receive the booster bivalent shot after two months.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: I had overlooked that the patient had already received a bivalent booster on 9/28/22 and a second bivalent booster was administered today.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Immunoglobulin therapy, Platelet count decreased
Clinical narrative: Low platelet levels after booster (as low as 14x10third) Have pulsed steroids several times, infused IVIG two days, now considering Retuxant protocols.  Currently platelets have hovered in the 30-60 range.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Incorrect dose administered
Clinical narrative: INADVERTANTLY GAVE REGULAR DOSE FLU INSTEAD OF HIGH DOSE- (WAS AVAILABLE) CLIENT NOTIFIED BY RN
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Potential use of expired Pfizer Pediatric Vaccine. Received information from the manufacturer indicating that stability data supports the use of this product for 18 months.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging normal, Tinnitus
Clinical narrative: Severe tinnitus
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Palpitations
Clinical narrative: Pt. complained of palpitations for 20 minutes then resolved on its own.